James R. Engle
Chief Tech/Sci/R&D Officer at Talecris Biotherapeutics Holdings Corp.
James R. Engle active positions
Companies | Position | Start | End |
---|---|---|---|
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Chief Tech/Sci/R&D Officer | 24/03/2010 | - |
Corporate Officer/Principal | 24/03/2010 | 24/03/2010 |
Career history of James R. Engle
Former positions of James R. Engle
Companies | Position | Start | End |
---|---|---|---|
Aventis, Inc. | Chief Tech/Sci/R&D Officer | 01/01/2004 | 01/01/2004 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Chief Tech/Sci/R&D Officer | - | - |
Training of James R. Engle
Delaware Valley University | Undergraduate Degree |
Statistics
International
United States | 5 |
Operational
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Talecris Biotherapeutics Holdings Corp.
Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Health Technology |
Aventis, Inc. | |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
- Stock Market
- Insiders
- James R. Engle
- Experience